Sponsor:
Unity Health Toronto
Code:
NCT02909517
Conditions
Ocular Melanoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
cSLO imaging
Brief summary:
Conditions
Ocular Melanoma
Study ID
NCT02909517
Start date
Mar, 2016
Status verified date
May, 2019
Completion date
May, 2020
Anticipated
Primary completion date
May, 2020
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
30 participants
Anticipated
Arms
Choroidal nevus
Choroidal indeterminate melanocytic lesion
Choroidal melanoma
Suspected metastatic tumour
Locally treated ocular tumour
Interventions
cSLO imaging
Primary outcome measure
Central contacts
Locations
St Michael's Hospital
Recruiting
Toronto, Ontario, Canada, M5B 1W8
Contacts
Princess Margaret Cancer Centre, Ontario
Recruiting
Toronto, Ontario, Canada, M5G 2M9
Contacts
Principal Investigator:
Fil Altomare, MD, FRCSC
Sponsor
Unity Health Toronto
Last update posted
May 23, 2019
Last verified
May, 2019
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Unity Health Toronto on 2019-05-23.